Answers are grounded in this paper and cite their sources.
Assessments of cellular metabolic function non-invasively, at high spatiotemporal resolution can provide important insights regarding cell state and fate relevant for the understanding, diagnosis and monitoring of numerous diseases and treatments. Methods that rely on the fluorescence intensity and lifetime characteristics of NAD(P)H and FAD, two co-enzymes involved in a number of key metabolic pathways, are becoming important tools for this purpose. This presentation will highlight efforts by several members of the biomedical optics community to establish guidelines on reporting of associated measurements to facilitate broad adoption and comparison of results from different studies. Specifically, I will describe recommended means of reporting evaluations of the: a) NAD(P)H and FAD fluorescence intensity-based optical redox ratio, and b) the NAD(P)H fluorescence lifetime-associated metrics based on time-domain and frequency (phasor)-domain analysis.
No takes yet. Share an insight, caveat, or question.
Irene Georgakoudi (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: